MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Young-Onset Parkinson’s Disease with Coexisting GBA1 Mutation and ATXN3 Repeat Expansion: A Double Hit?

    D. Yoo, K. Park, T. Ahn (Seoul, Republic of Korea)

    Objective: To report a rare case of young-onset Parkinson’s disease (PD) with a positive family history in which the patient was found to harbor double…
  • 2026 International Congress

    DCN-PPN Pathway Activation Improves Motor Dysfunction via Synaptic Plasticity in Parkinson’s Disease

    L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)

    Objective: To define the anatomical and functional connectivity of the DCN-PPN pathway, determine its alterations in PD, and investigate whether impaired synaptic plasticity in this…
  • 2026 International Congress

    Deep Brain Stimulation Outcomes in Parkinson’s Disease Patients With GBA1 Variants: A Systematic Review and Meta-analysis

    A. Hegazi, R. Mohamed, H. Hussein (Mansoura, Egypt)

    Objective: To compare motor, cognitive, and medication outcomes following deep brain stimulation (DBS) in Parkinson’s disease patients with GBA1 variants versus non-carriers Background: Variants in…
  • 2026 International Congress

    Early-Onset Parkinson Disease in 22q11.2 Deletion Syndrome:Diagnostic Challenges in a Patient With Schizophrenia.A Case Report

    L. Salinas-Yañez, J. Altamirano, D. Avecilla-Bonilla, K. Salinas-Barboza (CDMX, Mexico)

    Objective: To highlight 22q11.2 deletion syndrome (22q11.2DS) as an underrecognized genetic cause of early-onset Parkinson disease (EOPD) and to describe the diagnostic challenges in patients…
  • 2026 International Congress

    Plasma Proteomics in PSP

    S. Neo, S. Chia, J. Tan, T. Leong, Z. Xu, KY. Tay, WL. Au, LCS. Tan, A. Ng (Singapore, Singapore)

    Objective: We implemented an unbiased proximity extension proteomics assay to identify novel plasma PSP biomarkers. Background: Blood-based biomarkers can help to support non-invasive early diagnosis…
  • 2026 International Congress

    Various Levodopa Formulation effects on Local Field Potentials in Parkinson’s Disease

    A. Madamangalam, J. Cagle, C. de Hemptinne, J. Wong (Gainesville, USA)

    Objective: To describe the electrophysiological changes that occur in the brain with the use of foscarbidopa-foslevodopa and compare it to other common formulations of levodopa…
  • 2026 International Congress

    Modulatory effects of bacterial-derived serine protease on pathological α-synuclein fibrillation in vitro

    HJ. Yang, JI. Choi (Incheon, Republic of Korea)

    Objective: To investigate the modulatory effects of bacterial-derived proteins on the pathological aggregation of α-synuclein (α-syn) Background: Aggregation of α-syn into toxic oligomers and protofibrils…
  • 2026 International Congress

    Motor Network Neurophysiological (TMS-EEG) Markers as Predictors of Long-Term Outcomes Following Ventriculoperitoneal Shunt in Normal Pressure Hydrocephalus

    T. Davidy, A. Suminski, Y. Zauberman, T. Fay-Karmon, S. Anis, A. Saar, N. Zifman, H. Fogel, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: Assess the ability of Delphi-MD (TMS-evoked potential (TEP)-based test) to predict long-term (over one year) response to VPS as an ancillary tool to improve decision-making. Background:…
  • 2026 International Congress

    Passive smartphone-based tremor quantification in essential tremor

    J. Gerstl, S. Grigoriou (Lund, Sweden)

    Objective: To develop and evaluate the accuracy of a passive smartphone-based method for detecting and quantifying essential tremor (ET) severity. Background: ET is among the…
  • 2026 International Congress

    The Use of Digital Tools for Parkinson’s Phenotype Stratification to Improve Patients’ Selection for Advanced Therapies

    T. Diven, S. Lane, K. Muhammed, L. Agley, R. Ellis, J. Pannicker, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

    Objective: Leveraging multimodal patient data to identify distinct multidimensional subtypes of Parkinson’s Disease and improve patient selection for appropriate advanced therapies. Background: The management of Parkinson’s condition is becoming increasingly complex and demanding as the ageing population rises. The NHSE10…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley